EICHOR
● Active Not Recruiting
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Condition: Colitis, Ulcerative · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (403)
| Valley Gastroenterology Medical Group | Arcadia, California, United States | — |
| Southern California Research Center | Coronado, California, United States | — |
| Om Research LLC | Lancaster, California, United States | — |
| Cedars Sinai Medical Center | Los Angeles, California, United States | — |
| University of California San Francisco | San Francisco, California, United States | — |
| University of Colorado | Aurora, Colorado, United States | — |
| Peak Gastroenterology Associates | Colorado Springs, Colorado, United States | — |
| Medical Research Center of Connecticut | Hamden, Connecticut, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| MedStar Georgetown University Hospital | Washington D.C., District of Columbia, United States | — |
| Pioneer Research Solutions Inc. | Coconut Creek, Florida, United States | — |
| Digestive and Liver Disease Institute | Kissimmee, Florida, United States | — |
+ 391 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.